Vivos Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vivos Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Vivos Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -96.2 %, a 29% increase year-over-year.
  • Vivos Therapeutics, Inc. annual Operating Margin for 2023 was -125 %, a 19.8% increase from 2022.
  • Vivos Therapeutics, Inc. annual Operating Margin for 2022 was -156 %, a 29.4% decline from 2021.
  • Vivos Therapeutics, Inc. annual Operating Margin for 2021 was -121 %, a 31% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -125 +30.9 +19.8% Jan 1, 2023 Dec 31, 2023
2022 -156 -35.5 -29.4% Jan 1, 2022 Dec 31, 2022
2021 -121 -28.6 -31% Jan 1, 2021 Dec 31, 2021
2020 -92.2 +0.69 +0.74% Jan 1, 2020 Dec 31, 2020
2019 -92.8 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.